After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...
The brain-computer interface technology personalizes therapy based on an individual’s brain activity.
1d
News Medical on MSNMedtronic receives FDA approval for BrainSense Adaptive DBS technologyFor the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results